AFP464 in Treating Patients With Advanced Solid Tumors

NCT00369200 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

60

Enrollment

NIH

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: AFP464
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

National Cancer Institute (NCI)